Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenGO gonorrhoea prevention study with Bexsero
ACTRN12619001478101Phase 4Completed
- Sponsor
- Gold Coast Hospital and Health Service
- Start
- Jan 2020
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of meningococcal group B vaccine in gonorrhea (2 arms), sponsored by Gold Coast Hospital and Health Service. Primary endpoints: Number of Neisseria gonorrhoeae infections and Serum Neisseria gonorrhoeae antibody responses. Started Jan 2020; status: completed.
02
Drugs
meningococcal group B vaccine
03
Conditions
gonorrhea
Beyond the preview
Go deeper on ACTRN12619001478101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619001478101.